SCHEMBL23296302

SCHEMBL23296302

N#Cc1c(-n2c3ccccc3c3ncccc32)cc(-c2cccc(-c3ccccc3)n2)cc1-n1c2ccccc2c2ncccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
SQOR Q9Y6N5 4/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 2/20 0.36
CYP11B2 P19099 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
MEN1 O00255 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
TOP1 P11387 3/20 0.35
GAA P10253 2/20 0.35
GLA P06280 1/20 0.35
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADORA2B P29275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31273433 0.93 SQOR (0.38) PDE4APDE4CPDE4DSQORKDM4E
SCHEMBL31272927 0.92 SQOR (0.39) SQORKDM4EHPGDCYP11B2NPSR1
SCHEMBL31272446 0.90 SQOR (0.38) PDE4APDE4CPDE4DSQORKDM4E
SCHEMBL23342076 0.90 SQOR (0.38) PDE4APDE4CPDE4DSQORKDM4E
SCHEMBL23296368 0.89 TGFBR1 (0.39) SQORCYP11B2
SCHEMBL31273364 0.89 SQOR (0.38) PDE4APDE4CPDE4DSQORKDM4E
SCHEMBL23296342 0.89 SQOR (0.39) PDE4DSQORKDM4ECYP11B2ALDH1A1
SCHEMBL23296423 0.88 KMT2A (0.43) SQORKDM4EHPGDNPSR1RXFP1
SCHEMBL31273346 0.88 KMT2A (0.43) SQORKDM4EHPGDNPSR1RXFP1
SCHEMBL23342510 0.86 ABCG2 (0.38) SQORKDM4EHPGDCYP11B2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 PDE4A 4147/4885PDE4C 3854/4885PDE4D 3459/4885
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 PDE4A 4147/4885PDE4C 3854/4885PDE4D 3459/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 PDE4A 4147/4885PDE4C 3854/4885PDE4D 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.